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The hemodialysis catheter conundrum: Hate living with them, come to play an increasingly important role in the deliv-
but can’t live without them. ery of hemodialysis. These catheters are of great value
Background. Hemodialysis requires reliable recurrent ac- in situations where an immediate vascular access is re-cess to the circulation. On a chronic basis, this has been best
quired and have come to be increasingly used in patientsprovided by the use of arteriovenous fistulae and arteriovenous
with chronic renal failure. Clinical practice has led tografts. In recent years, hemodialysis catheters have come to
play an increasingly important role in the delivery of hemodial- the emergence of two distinct classes of catheter access:
ysis. The use of both temporary as well as cuffed hemodialysis (1) temporary or acute catheters and (2) chronic or tun-
catheters has emerged as a significant boon for both patients neled cuffed catheters. Data collected by the Unitedand practicing nephrologists. The complications, however, as-
States Renal Data System indicate that in 1996, 18.9%sociated with each of these hemodialysis catheters, both in
of all new hemodialysis patients were being dialyzed withterms of anatomic, thrombotic, and infectious issues, have
emerged as a major problem with their continued use. This a tunneled cuffed catheter and 12.9% were still using a
significant morbidity and complication rate has forced many catheter 60 days after starting dialysis [1]. This number
nephrologists to face a basic conundrum: they have come to has been progressively increasing; in 1993 only 9.7% ofhate having to deal with the problems inherent in catheter
patients were using a tunneled cuffed catheter 30 daysusage, but the enormous utility of these devices have forced
after the initiation of dialysis.physicians to accept the fact they cannot live without them in
their current practice. While some catheter use is inappropriate, there is no
Methods. We used a comprehensive literature review to de- doubt that dialysis access catheters have come to be an
scribe the types, use and dilemmas of hemodialysis catheters.
important tool in the management of patients requiringResults. This article provides a comprehensive review of
hemodialysis. The primary reason for this is that cathe-both the benefits inherent with the use of these hemodialysis
catheters while cataloging their complications and offering ters can be used in virtually any patient, they are easily
some possible solutions. inserted, and they are suitable for immediate use follow-
Conclusion. Hemodialysis vascular access catheters are es- ing insertion. Table 1 illustrates the variety of instances
sential in the maintenance of hemodialysis vascular access.
in which catheters are used.However, they have a significant infectious, thrombotic, ana-
Unfortunately, as we have learned all too well, thetomic complication rate that are detailed with proposed prob-
lem-solving guidelines. dialysis access catheter is a double-edged sword. The
tremendous advantages that it brings can also carry a
tremendous cost. This has forced many nephrologists to
Hemodialysis requires reliable, recurrent access to the face a basic conundrum. They have come to hate having
circulation. On the chronic basis, this has generally been to deal with the problems inherent with catheter usage,
provided by either an arteriovenous (AV) fistula or by but have had to accept the fact that they can’t live without
a prosthetic bridge graft (AV Graft) composed of polyte- them. Our purpose is to review the problems related to
trafluorethylene (PTFE). In recent years catheters have catheter use and to present some possible solutions to
these problems.
Key words: dialysis, renal replacement therapy, arteriovenous fistula,
thrombosis, infection, vascular access.
TEMPORARY CATHETERS
Received for publication July 16, 1998 Originally, acute vascular access for hemodialysis wasand in revised form November 20, 1998
provided by the use of venous and arterial trocars. ThisAccepted for publication December 21, 1998
Updated January 28, 1999 was replaced by the use of either a single lumen dialysis
catheter that required an intermittent flow device or two 1999 by the International Society of Nephrology
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Table 1. Uses of the tunneled-cuffed catheter
Temporary catheters
Acute renal failure
Maturing AV access (3 weeks or less)
Intoxication
Plasmapheresis
Chronic catheters (tunneled cuffed)
Same as temporary catheter, but requiring more than 2–3 weeks
Fig. 1. Acute catheter schematic showing catheter and distal tip.of dialysis
(Adapted from Fan [2]; used with permission of the author and W.B.Anticipated living-related donor transplantation
Saunders Company.)Maturation of peritoneal dialysis access
Maturing AV access
Failure of AV vascular access
Bridge following infection and removal of access
TUNNELED CATHETERS
Cuffed, tunneled hemodialysis catheters were devel-
oped in 1987 as an alternative to acute hemodialysis
separate dialysis catheters for simultaneous inflow and vascular access (Fig. 2) [3, 4]. These catheters are usually
outflow [2]. Subsequent design modifications and im- constructed of silicone or silastic elastomer, which is
much softer and pliable than the material generally usedprovements have led to a near universal standard for
for acute hemodialysis catheters. For this reason, theseacute hemodialysis catheters. This design is character-
catheters are usually inserted using a peel-away sheathized by dual lumens arranged coaxially in a single cathe-
that has been placed into the vein using the Seldingerter (Fig. 1). To minimize recirculation of blood and allow
technique. The use of a tunnel and a bonded cuff servea continuous blood path, the catheter is designed with
to anchor the dialysis catheter in the tunnel, and presum-the arterial port proximal to the venous and separated
ably, prevent migration of bacteria down the outer sur-from it by 2 to 3 cm (Fig. 1).
face of the catheter. The soft silastic elastomer allowsTemporary catheters are characteristically composed
the use of larger lumen size and placement of theseof rigid materials such as polyurethane or polyvinyl.
catheters with their tip in the right atrium. A largerThese materials are relatively stiff at room temperature
lumen permits greater blood flows than is possible with
to allow for ease of insertion over a guidewire without the smaller temporary catheters. To achieve the blood
requiring a sheath. They become more pliant and flexible flow benefits of the larger lumen, flouroscopy is required
at body temperature within the bloodstream, and this to assure positioning in the right atrium. The cannulation
serves to minimize the risk of vessel damage [2]. Tempo- hole in the vein is also larger because the peel away
rary catheters are characteristically non-cuffed and are sheath is larger than the catheter.
not tunneled at the time of placement to allow rapid The original tunnel hemodialysis catheter was mar-
access to the circulation with minimal patient trauma. keted by Quinton Instrument Co (Perm Cathe, Quinton
They are available in a variety of lengths, adaptable for Instrument Company, Seattle, WA, USA) and was a large
oval catheter with two distinct circular lumens (Fig. 3).use in any accessible central vein. These devices are
Subsequent designs utilized a round catheter with a cen-suitable for use for a period of days to weeks. These
tral septum to facilitate easier peel-away introducer in-characteristics that emphasize simplicity and ease of in-
sertion (Vas Cath; Bard, Salt Lake City, UT, USA; andsertion allow rapid access to the circulation at the bedside
others; Fig. 3). The third popularized design includedwithout requiring flouroscopy or other radiologic sup-
the use of two separate single lumen catheters with theport [2].
inflow catheter in the proximal superior vena cava and theTemporary catheters offer the advantages of ease of
return catheter with one tip in the right atrium (Tesioe;placement. They can be inserted at the bedside using a
Medcomp, Harleysville, PA, USA; and others; Fig. 3).sterile Seldinger technique. While blood flow is limited
Modifications of the Tesioe design to fuse the two sepa-
with most of these catheters, they generally provide a rate catheters at some point along its length to allow
blood flow (200 to 250 ml/min) that is adequate for short- insertion in a single sheath has become popular (ASH
term usage. Newer temporary catheter designs have uti- Catheter, Medcomp, Harleysville, PA, USA). The most
lized silicone and have incorporated a larger diameter recent design modification is to connect the catheters to
that is said to provide blood flow of 400 ml/min or greater. totally subcutaneous ports (LifeSite; VascA, Topsfield,
Because of the flexibility of these silicone temporary MA; and Dialock; Biolink Inc., Boston, MA, USA). This
catheters they must be inserted using a disposable trocar design avoids complications associated with a transcuta-
or a peel-away sheath substituting complexity for an neous device (Fig. 4).
Initially intended as a bridge device to provide pro-increase in blood flow.
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Fig. 2. Schematic of a cuffed tunneled cathe-
ter. (From Schwab et al [3], used with permis-
sion of W.B. Saunders Company.)
Table 2. Complications of catheter usage
Limited ability to provide adequate dialysis
Related to size of catheter
Diameter
Length
Recirculation
Placement problems
Complications of placement
Tip location
Thrombosis
Extrinsic
Intrinsic
Infection
Exit site
Tunnel
Catheter-related bacteremia
Table 3. Poiseuille’s LawFig. 3. Cross sectional schematic of three commonly used catheters.
(From Athirakul et al [7]; used with permission from Nephrology, Dial-
Laminar blood flow 5k(P3D4)/(L3V)ysis Transplantation.)
P – pressure
D – diameter
L – length
V – viscosity
K – proportionality constant
is that when a problem occurs with a temporary catheter,
the alternative of disposing of the catheter is more likely
to be possible. The success of any plan to use a catheter,
either short-term or prolonged, is largely dependent
upon how well these complications can be managed.
CATHETER FLOW
The primary determinants of catheter blood flow are
catheter size dimensions and tip placement. As with flow
through any tubular structure, blood flow through a cath-
eter is related to the diameter and length of the device.Fig. 4. Lifesite port (VascA, Topsfield, MA, USA) constructed of a
This relationship between these variables is expressedtitanium alloy. This port is designed to be placed subcutaneously. It is
entered using a standard 14-gage dialysis needle. Two ports are placed, in Poiseuille’s Law (Table 3). The major catheter-related
one to serve as the arterial and the other the venous access. The 12 determinant of flow is its diameter. Flow increases inFrench catheters are placed into the right internal jugular vein.
direct proportion to an increase in diameter raised to
the fourth power. This relationship dictates that by in-
creasing the diameter by only 19%, the flow will be in-
creased by a factor of two. There is an inverse relationshiplonged periods of temporary access, cuffed tunneled cath-
eters have emerged to fill a much greater role (Table 1). between flow and catheter length, but it is not as impor-
tant a determinant as diameter. Actually, increasing theRegardless of the type of catheter, temporary or tun-
neled, or its design, there are certain complications that diameter by only 19% can compensate for a doubling
of length. Because resistance to pumped blood flow isare associated with all catheter usage (Table 2). In general
these complications are the same. The major difference generally higher when a catheter is used as the vascular
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access, pre-pump (dialyzer inflow) pressures are likely designs placed in the internal jugular position with right
atrial tip placement is shown in Table 4 (Fig. 3) [7]. Theto be lower (more negative) than with either an arterio-
venous (AV) fistula or a prosthetic bridge graft [5]. Nega- poor performance of the central septum catheter (Vas
Cathe) was based on lumen diameter. The relativelytive pre-pump pressures result in a partial collapse of
the blood line pump segment, rendering the pump RPM small size of the central septum catheter, in contrast,
made it the easiest to insert. Larger diameter centralmeter highly inaccurate as a measure of dialyzer blood
flow. Depner, Rizwan and Stasi reported a decrease of septum catheters would be expected to flow better but
be more difficult to insert. Ultrasound dilution determi-8.5% in blood flow measured volumetrically compared
to the blood pump meter reading when a pressure of nation of catheter blood flow under these circumstances
determined that mean flow under these conditions for2200 mm Hg was applied to the tubing [6]. This differ-
ence increased to 33% when a negative pressure of 2400 all tested catheter types was 10 to 15% less than the
blood pump predicted. When pre-pump pressure ex-mm Hg was applied. Thus, when pre-pump pressures
fall below 2200 to 250 mm Hg the pump read flow ceeded (that is, were more negative than) 200 mm Hg
(as was almost always the case when the blood pumpreadings become progressively more inaccurate. This ex-
plains the significant falls in dialysis efficiency despite was set for 350 to 400 ml/min; Table 4) blood flow, mea-
sured by ultrasound dilution, averaged 20 to 30% lessnear equivalent blood pump flow readings and dialysis
times when catheters are substituted for AV access. than pump read blood flow (Table 4). Thus, increasing
blood pump speed when pre-pump pressure exceeds neg-Elevated venous (dialyzer outflow) pressure occurs in
a subset of patients. This usually reflects placement in a ative 200 to 300 mm Hg leads to a limited improvement
in actual net blood flow. Patients will almost always re-smaller vessel or placement near a venous bend with
the catheter tip placed up against the vessel wall. An quire an increase in dialysis duration when the access is
changed from an AV access to a dialysis catheter.alternative explanation is a partial venous out flow lumen
thrombus. As with the temporary catheter, there appears to be
an inverse relationship between ease of placement andIn the past, temporary or acute catheters have adhered
to a small diameter design, 10 to 12 French, to facilitate catheter flow capability. Nevertheless, the primary deter-
minant used to select a catheter for chronic use shouldease of bedside insertion. As a result of this design, these
catheters have characteristically provided blood flows of be the flow that it can provide. Ease of placement must
be a secondary issue for temporary catheters unless theonly 200 to 250 ml/minute. Design compromises were
developed to maximize ease and safety of insertion at patient and the physician are willing to significantly in-
crease treatment duration to compensate for the dimin-the cost of dialysis efficiency. When used for relatively
short periods of time these compromises were well rea- ished flow. The DOQI guidelines define sufficient extra-
corporeal blood flow as 300 ml/min [8]. However, thissoned and readily apparent. Recently, larger caliber tem-
porary catheters have been produced with diameters of should be regarded as a minimum criterion, not the opti-
mum. In practice, when using hemodialysis catheters a14 French, said to be capable of faster blood flows but
at the cost of ease of insertion. In selecting a temporary true blood flow of 300 ml/min may require a pump read
flow of 350 to 400 ml/min.catheter for general use these compromises must be un-
derstood. Longer treatment times at lower blood flows With the use of catheters, recirculation is dependent
upon two factors: the location of the catheter tip andare required to deliver an adequate dose of dialysis.
Temporary catheters are generally inserted without the the status of the patient’s central circulation. Catheters
with their tips placed in smaller blood vessels are moreuse of real-time fluoroscopy. Blind placement of a rela-
tively stiff device through the right internal jugular vein prone to recirculation than catheters placed in larger
blood spaces. Thus, there is a greater likelihood of recir-has created the necessity of using a short catheter to
avoid atrial perforation. The tip of these catheters comes culation when a femoral catheter is used versus an inter-
nal jugular or subclavian. Soft right atrial catheters areto be located in the in the proximal superior vena cava,
and this tip location in smaller blood vessels does not least likely to show recirculation. Kelber, Delmer, and
Windus reported recirculation rates of 4%, 5% and 10%allow for as great a blood flow as catheters located in
the distal superior vena cava and the right atrium. for internal jugular, subclavian and 24 cm femoral cathe-
ters, respectively [9]. They reported an 18% recirculationTunneled cuffed catheters were introduced to provide
for longer periods of use than temporary catheters but rate with a 15 cm femoral catheter. Other investigators
reported negligible recirculation in right atrial cathetersrequire fluoroscopy for placement to use their full blood
flow potential [2–4]. These cuffed tunneled catheters [7]. This changes dramatically if the lumens are reversed,
approaching 20% [7]. The more centrally the tip is lo-vary in configuration and size, both diameter and length
(Figs. 2 and 3). As a consequence, the flow that can be cated, the less likely recirculation is to occur. In placing
tunneled catheters in the femoral vein with real-timeexpected from the use of various catheters will vary. In
a prospective study, the mean blood flow of the various fluoroscopic guidance, we (GAB) have found that in
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Table 4. Catheter blood flow capabilities
Catheter type
Perm CathE TesioE VAS Cath “Soft Cell”E
Mean blood pump
QB ml/min 384628.5 396 645.1 320 662
Mean QB ml/min
Ultrasound dilution 301621 307 628 229 640
Pre-pump pressure
(mean) 320 mm Hg 330 mm Hg 360 mm Hg
Table 5. Complications of initial catheter placement niques [23]. The reason that even very experienced oper-
ators have problems with blind central vein cannulationArrhythmias
Pneumothorax is the variability that exists in the venous anatomy. In
Bleeding an ultrasonic evaluation of 104 patients, Lin et al foundHematoma formation
that 27% of the cases had internal jugular vein anatomi-Arterial puncture
Hemothorax cal variations that would have contributed to difficulty
Air embolism in external landmark-guided cannulation [24]. In theHemomediastinum
chronic hemodialysis population it is not at all unusualRecurrent laryngeal nerve palsy
Cardiac arrest to discover the absence of an internal jugular vein when
Atrial perforation the patient is evaluated with ultrasound (at Duke Uni-Improper tip placement
versity 18% of patients referred for catheter insertion
had thrombosed, occluded or absent right internal jugu-
lar veins). Real-time ultrasound guided cannulation was
strongly recommended by the DOQI committee on vas-most patients a 45 to 50 cm catheter is required for the
cular access [25]. This is probably too conservative, ittip to lie within the inferior vena cava.
should be considered a standard part of the procedure
(Fig. 5). The availability of small inexpensive ultrasound
CATHETER PLACEMENT cannulation machines makes ultrasound observation and
Complications of placement confirmation of vessels to be cannulated prior to cannula-
tion possible even for bed side cannulation (SITEAs listed in Table 5, a variety of complications can occur
RITEe, Pittsburgh, PA, USA). Experienced physiciansat the time of catheter placement. The major determinant
who dislike the added complexity of real time cannula-for problems at the time of insertion is the experience of
tion are still well served by confirming vessel locationthe operator [10] and whether real-time visualization
and patency prior to cannulation.techniques are used. Even in the hands of experienced
Long-term complications of catheter placement aresurgeons in the operating room, blind insertion results
also important. For over a decade the relationship be-in complication rates as high as 5.9% [11, 12]. These
tween central venous catheters, particularly subclaviancomplications include: pneumothorax (0 to 1.8%), hemo-
catheters, and central venous stenosis has been recog-thorax (0 to 0.6%), hemomediastinum (0 to 1.2%), recur-
nized [26–29]. This has been a serious problem with therent laryngeal nerve palsy (0 to 1.6%), and bleeding that
use of temporary catheters (Fig. 6). The incidence ofrequired re-exploration and/or transfusion (0 to 4.7%)
subclavian stenosis following catheter placement has[3, 4, 11–19]. This contrasts with the series reported by
been reported to be in the range of 42 to 50%. In contrast,Trerotola et al using real-time ultrasound guidance [20].
the rate of innominate stenosis following use of the inter-Their complication rate was limited to 2 cases (0.8%)
nal jugular vein has been reported to be 0 to 10% [30,of small, clinically silent air embolism in 250 catheter
31]. In these reports, the catheters were not tunneledplacements.
and were placed without imaging guidance. Thus, theThe use of ultrasound-guided cannulation has resulted
DOQI guidelines recommended that subclavian veinin an substantial decrease in procedural complications
cannulation should be avoided except as a last resort [8].[21, 22]. Randolph et al performed a meta-analysis of
When a temporary catheter is left in place for a pro-the literature and concluded that ultrasound guidance
longed period, progressive vascular erosion can occurdecreased central venous catheter placement failure (rel-
and lead to perforation. This is related to the lengthative risk of 0.32), decreased complications from catheter
and relative rigidity of these devices. Improper catheterplacement (relative risk of 0.22), and decreased the need
positioning or migration of the tip out of the proximalfor multiple catheter placement attempts (relative risk
of 0.60) when compared to landmark cannulation tech- superior vena cava increases the risk of this occurrence.
Schwab et al: The hemodialysis catheter conundrum6
Fig. 5. Ultrasound appearance of right internal jugular vein (Vein) and carotid artery (Artery). With visualization of this type, cannulation of
the internal jugular is easily accomplished.
This can result in a hemothorax or atrial perforation and ral placement of a temporary dialysis catheter offers
a convenient means for short-term vascular access. Inpericardial tamponade [2]. In general, temporary non-
cuffed catheters inserted in the femoral position may be general, patients with a femoral temporary catheter
should not be allowed to ambulate. Femoral placementleft in place in bed bound patients for three to five days
prior to needing removal and replacement. Temporary of a tunneled catheter is an attractive alternative in pa-
tients in the intensive care unit, especially when the pa-catheters placed in the internal jugular position charac-
teristically have a use life of no more than two to three tient is on a respirator. In patients with head and neck
trauma, patients with multiple central venous linesweeks because of the increasing risk of catheter related
bacteremia [2, 3]. around the neck and chest and patients with a tracheos-
tomy, moving the dialysis access to the lower extremity
Selection of site of placement makes it more convenient and more easily managed.
The right internal jugular is the preferred initial access
Placement of catheter tipsite for cuffed tunneled catheter placement because of
the relative direct path to the superior vena cava (SVC) Improper tip placement is a common cause of poor
flow. The tip of a temporary non-cuffed catheter placedand the right atrium, and the relative low incidence of
central vein stenosis. The second choice for placement in the neck or chest should extend to the superior vena
cava. Shorter catheters may be plauged by excessiveof a catheter is not clear. The left internal jugular is a
less desirable access site. In order for the catheter to recirculation and catheters that are longer present the
risk of atrial perforation. The optimal length for an inter-reach the right atrium it must traverse two curves, in
contrast to the single curve required of the subclavian nal jugular catheter is 15 cm. Femoral placement de-
mands a longer length catheter in order to minimizecatheter. Not only does a catheter in this position risk
stenosis, it also has a higher malfunction rate [24]. The recirculation. Optimally, these catheters should read the
inferior vena cava. Unfortunately, the longest lengths ofsubclavian site allows excellent function but has a high
rate of central vein stenosis and should therefore be temporary catheters (25 cm) in common usage are not
quite long enough to do this. Rigid temporary cathetersavoided [26–30]. In cases in which all easily accessed
sites have been depleted, translumbar [32], transhepatic should never be placed in the right atrium because of the
risk of vessel puncture and catheter induced arrhythmia.[33] and femoral catheters [34] have been used for the
placement of tunneled catheters. These sites have higher Because the cuffed tunneled catheter is constructed
of soft material (silicone, silastic elastomer), there is littledysfunction and infection rates than the other insertion
sites. risk of atrial perforation. Therefore these catheters can
be, and if fact should be, longer. Placing the tip of theFor single use or in patients confined to the bed, femo-
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Fig. 6. Venogram of left subclavian showing area of severe stenosis (arrow).
catheter into the atrium is safe and minimizes the risk applied. With twin catheters, tip positioning is not a
factor, however, the venous element should extend 3 toof recirculation. There is also the problem of catheter
4 cm beyond the arterial one to minimize recirculation.retraction. The tunneled catheter usually does not be-
comes attached to the tissue except at the cuff. The
Catheter thrombosis: Patencycatheter moves back and forth within the tunnel in asso-
In general, catheter blood flow problems that occurciation with changes in anatomic position. The chest wall
early after placement are related to catheter positiontissues move downward when the supine patient (as at
while those that occur late are related to thrombosis.the time of catheter placement) assumes an erect posi-
Thrombosis is a common problem with both temporarytion (as at the time of dialysis). Since the catheter cuff
and cuffed tunneled catheters, and the problems encoun-is anchored in this tissue, it retracts. At times, this retrac-
tered with these two types of catheters are similar. Thetion can be considerable (Fig. 7). Thus, change in patient
major difference lies in the fact that when flow problemsposition can materially affect catheter flow. The tip of a
occur with the temporary catheter, it is often easier totunneled catheter should be placed within the atrium at
just exchange it over a guidewire than deal with thethe time of insertion and should span the caval-atrial
range of solutions offered for its cuffed tunneled cousin.
junction on an erect inspiratory film (Fig. 7B). A catheter The mean primary patency rate (time to first required
positioned with the tip at the caval-atrial junction may therapeutic intervention) for tunneled catheters has been
not work in the dialysis unit, especially in obese patients reported to range from 73 to 84 days [35, 36]. Reported
and patients with large breasts as the catheter when the cumulative patency rates (time from placement to cathe-
patient is sitting may retract well above the atrial caval ter site failure) vary widely. The DOQI panel concluded
junction. Fluoroscopy is required to optimize cuffed tun- that a 12 month patency was a believable estimate [8].
neled catheter placement. Catheter associated thrombosis can be classified as ex-
The optimum orientation of the catheter tip is impor- trinsic and intrinsic (Table 6).
tant for proper function and good flow. First, with double
Extrinsic thrombosislumen catheters, the red hub (arterial lumen) should be
turned medially, away from the vessel wall. This will Central venous thrombosis. The presence of a catheter
within the central veins can precipitate thrombosis ofprevent it from adhering to the wall when suction is
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Fig. 7. (A) Appearance of tunneled cuffed catheter with patient supine. Contrast has been injected to facilitate visualization of the catheter. The
arrow indicates the position of the tip. Note that it is in the lower atrium. (B) The same patient as shown in A. This film was taken with the
patient erect. Notice the difference in the position of the catheter tip as indicated by the arrow. Note the degree of retraction that has occurred.
This catheter position is considered optimum.
Table 6. Classification of catheter thrombosis it does occur the symptoms can be dramatic. Diagnosis
is based primarily upon the clinical picture presented byExtrinsic
Mural thrombus the patient. The patient presents with swelling of the
Central vein thrombosis
ipsilateral extremity, which may also be tender and pain-Atrial thrombus
Intrinsic ful. The presence of central vein thrombosis may be
Intraluminal confirmed by the use of ultrasound evaluation of venog-
Catheter tip thrombus
raphy. Treatment consists of catheter removal and anti-Fibrin sheath
coagulation. In cases in which the potential sites for
vascular access are depleted or extremely limited, it
may be possible to preserve the catheter. These patients
must be systemically anticoagulated and observed verythe vein. How often this occurs is not clear. Agraharkar
closely. Some investigators have reported success withet al suggested that it is not common [37], and reported
direct urokinase infusion [39]. The catheter must be leftan incidence of only 2% in a series of 101 percutaneously
in place to prevent bleeding from the catheter site if thisinserted catheters. Karnik et al, in a study of 63 patients
therapy is attempted.with central venous catheters (not dialysis), found an
Mural thrombus. This is a thrombus that is attachedincidence of 63.5% [38]. It is certainly clear that symp-
tomatic central vein thrombosis is not common, but when to the wall of the vessel or the atrium at the point of
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contact by the tip of the catheter. It is presumed that may be occlusive, or it may act as a ball valve. Preventa-
tive measures that are commonly used to avoid intralum-catheter tip movement causes damage that results in
inal thrombosis are largely subverted by the presence ofthrombus formation. The tip of the catheter is frequently
the side holes. It is probable that forcible flushing beforeattached to this mural thrombus, and when this occurs,
and after dialysis does aid in clearing poorly attachedit can interfere with catheter function. Most of these
catheter tip thrombi. Urokinase instillation (lock) usu-thombi are not recognized unless there is catheter mal-
ally revolves this thrombosis.function, at which time they may be recognized at the
Fibrin sheath thrombus. This is the most difficult totime of angiographic evaluation. When recognized, re-
treat of the intrinsic conditions. In fact, this could equallymoval of the catheter accompanied by 3 months of anti-
well be considered an extrinsic condition, but is discussedcoagulation is indicated, and in our experience repre-
here to facilitate a step-wise evaluation of the problem.sents adequate treatment. A large mural thrombus raises
The term fibrin sheath refers to a sleeve of fibrin thatthe risk of a significant embolism when the catheter is
surrounds the catheter starting at the point where itremoved. A suitable therapy for this problem has not
enters the vein. This sheath is only loosely attached to thebeen developed, and our practice is to remove these
catheter. It is probable that all central venous catheterscatheters under real time observation so that immediate
become encased in a layer of fibrin within a few days oflytic therapy can be employed if indicated.
insertion. Hoshal, Ause and Hoskins reported a fibrinAtrial thrombus. Rarely, a large intra-atrial thrombus
sheath in 100% of 55 patients with central venous cathe-may develop in association with a dialysis catheter and
ters at autopsy [41]. These are not always symptomatic.present as a mass within the right atrium as seen angio-
The incidence of catheter dysfunction secondary to fibringraphically or with an echocardiogram [40]. This proba-
sheath has been reported to be 13 to 57% [35]. When ably represents a variant of the mural thrombus. Removal
catheter is removed, gentle angiography of the catheterof the catheter, anticoagulation and echocardiographic
can demonstrate a “wind sock” of residual fibrin sleevefollow-up have been used in these cases. Real time cathe-
(Fig. 8) in approximately 40% of cases [42]. As the sheathter removal with lytic therapy on standby in case a large
extends downwards, it eventually closes over the tip ofpulmonary embolism develops is probably warranted.
the catheter. In this position, it can be disrupted by in-
ward pressure to create a flap-valve that will allow injec-Intrinsic thrombosis
tion but prevents withdrawal of blood and fluid.This type of thrombosis represents the major compli-
Fibrin sheath formation generally causes catheter dys-cation associated with dialysis access catheters.
function weeks or months after catheter placement; how-
Intraluminal thrombus. Intraluminal thrombosis oc-
ever, it may be seen as early as 48 hours. It is not clear
curs when a thrombus forms within the catheter lumen. whether or not prevention of the formation of a fibrin
It results from either an inadequate volume of heparin sheath is possible. There is anecdotal experience to sug-
being placed within the catheter lumen, heparin being gest that chronic systemic anticoagulation with warfarin
lost from the catheter between dialysis treatments, or is beneficial, at least in selected patients. There are multi-
from the presence of blood within the catheter. Uroki- ple treatment regimens discussed below. However, pa-
nase instillation characteristically resolves these throm- tients who form a fibrin sheath are likely to reform a
boses. The vascular access DOQI provides two urokinase sheath.
instillation or lock techniques. One technique involves
placing urokinase (1 ml/5000 m) in a volume sufficient Prevention of catheter malfunction
to fill the catheter followed by aspiration in 20 minutes. Chronic anticoagulation with either warfarin or low
The alternate technique is similar but uses small injec- molecular weight heparin has garnered anecdotal sup-
tions of saline to advance the urokinase to the catheter port for preventing both lumen thrombus and fibrin
tip at 5 to 10 minute intervals. sheath formation on hemodialysis catheters. To date no
Heparin of 1 ml/5000 m or 1 ml/10,000 m should be prospective clinical trials have been published. Currently
placed in the catheter at the conclusion of each hemodial- clinical trials are underway in the U.S. and Canada to test
ysis treatment. The catheter should be filled to its capac- partial and systemic anticoagulation with both classes
ity; capacity of the catheter is labeled on the catheter of agents in a prospective controlled format. Similarly,
for each lumen. The catheter should be have tape labels prospective trials of urokinase as an alternate to heparin
marked with the date of instillation describing the type locked in the catheter between treatments as a means
of quantity of heparin instilled on each lumen with a of diminishing both lumen thrombus and fibrin sheathing
warning “do not flush.” are underway.
Catheter tip thrombus. Many catheters have side holes
Treatment of catheter malfunctionat the tip of the arterial limb. Unfortunately, the portion
of the catheter from the side holes to the tip will not The first step in the management of catheter malfunc-
tion is the recognition of the problem. Early malfunctionretain heparin and a thrombus can form. A tip thrombus
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methods for acute or temporary catheters may be consid-
ered excessive in view of the ease that these devices
can be exchanged over a guidewire. Treatment can be
categorized as primary and secondary.
Primary treatment of catheter malfunction. Primary
treatment of catheter malfunction refers to the treatment
that can be immediately applied in the hemodialysis fa-
cility.
Urokinase. Numerous protocols for urokinase admin-
istration or urokinase catheter lock are in use. Two effec-
tive examples are provided in the Vascular Access DOQI
Guidelines. Proper use of intraluminal urokinase has
been shown to be successful in restoring catheter func-
tion in 74 to 95% of cases [3, 35]. The advantages of the
urokinase technique are that it has a high rate of success
in treating intraluminal thrombus, produces no systemic
effect and is therefore safe, and can be performed by a
trained nurse in the hemodialysis facility.
Urokinase catheter lock is not a good solution for the
treatment of a fibrin sheathing. Thrombolysis only occurs
within the catheter and at its tip. There is no systemic
effect and no mechanism by which the enzyme can come
into contact with the major portion of the sheath. At
Duke University preliminary results of a 30 minute infu-
sion of 20,000 units of urokinase in to the affected cathe-
ter lumen has been 70% effective in restoring function
after failure of the urokinase lock technique. This low
dose protocol is affordable and can be performed in the
hemodialysis unit. Recently, Twardowski has reported
a series of high dose urokinase infusions for catheter
dysfunction performed during the hemodialysis treat-
Fig. 8. The appearance of a fibrin sheath. The arrow indicates the tip ment itself [43]. These urokinase infusion protocols holdof the catheter that has been partially removed in preparation for a
promise and are undergoing clinical trials at several cen-catheter exchange. The fibrin sheath can be seen hanging below the
catheter in its original position. ters. Whether the low dose (20,000 to 40,000 units or the
higher dose 125,000 to 250,000 units) will be equally
successful or whether one is able to open the catheter
well enough to perform another infusion during the treat-
is usually due to improper placement with poor tip posi- ment awaits the results of the trials. In a similar fashion
tioning or subcutaneous kinking of the catheter. With the value of slow infusion versus rapid injection is under
temporary catheters, repetitive bending of the relative study. Regardless, the current problem of the unreim-
stiff device will eventually lead to fatigue of the material bursed expense of urokinase in the hemodialysis unit
and kinking due to collapse. This may be confused with represents a current barrier to consideration of the high
thrombosis. Although it is possible for a tunneled cathe- dose urokinase intradialytic protocols in the United
ter to become displaced after it has been in satisfactory States.
use for a period of time, later cases of malfunction are Secondary treatment of catheter malfunction. If the
generally due to thrombosis. primary treatments are unsuccessful or if the problem
Catheter malfunction is defined as a failure to attain quickly recurs, a radiographic study using contrast should
and maintain an extracorporeal blood flow sufficient to be performed. Further secondary treatment should be
perform hemodialysis without significantly lengthening performed based upon the radiographic findings. These
the hemodialysis treatment. Sufficient extracorporeal treatments are usually not performed in the hemodialysis
blood flow is considered to be 300 ml/min [8]. Once facility. Appropriate treatments include:
catheter malfunction is recognized it should be immedi- (a) Fibrin sheath stripping. The fibrin sheath can be
ately treated. The approach to treatment may be differ- stripped using a snare catheter (Fig. 9). The snare is
ent for temporary catheters versus tunneled catheters. introduced through the femoral vein from where it is
advanced up to the level of the dialysis catheter. TheThe expense and difficulty of some of the treatment
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Fig. 9. Snare around a fibrin sheath prior to
catheter fibrin sheath stripping. (From Su-
hocki [35], used with permission by the author
and W.B. Saunders Co.)
reported success of this procedure ranges from 92 to prior to inserting the new catheter. It is possible to place
the new catheter back into the retained sheath and have98% [35, 42, 44], and the reported duration of patency
has varied from a mean of 20 days to a mean of 90 days. the same problem within a short time. To avoid this
complication, the sheath can be removed (embolized)Fibrin sheath stripping generally results in asymptomatic
embolization of the fibrin sheath. using an 80-cm Fogarty embolectomy balloon.
Advantages of this procedure are that it preserves theAdvantages of this technique are high success rate,
safety, it preserves the catheter and the duration patency exit and venotomy site and has a low reported complica-
tion rate, is less expensive than fibrin sheath stripping,is reasonable.
(b) Catheter exchange over guidewire. This technique and it has a high rate of success. Disadvantages of this
technique are that a new catheter exit wound is createdcan be effectively used to eliminate the problem of cathe-
ter thrombosis (abstract; Duszak et al, Radiology 197: with its associated risks of bleeding and infection.
(c) Urokinase infusion. Treatment of catheter throm-284, 1995). This can be done using a technique that pre-
serves both the exit site and the venotomy site. It is bosis by prolonged administration of urokinase has been
used. This involves the administration of 20,000 units ofimportant that the patient be checked for a fibrin sheath
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urokinase per hour for four to six hours. Lund et al that have been identified as risk factors for the develop-
reported a success rate of 79.5% with this technique [36]. ment of CRB [51–54]. These include skin and nasal colo-
This dose of urokinase is not large enough to result in nization with staphylococcus, catheter hub colonization,
systemic effects and does not require hospital admission. duration of catheterization, thrombosis, frequency of
Other urokinase protocols both published and under catheter manipulation, diabetes mellitus, iron overload,
investigation were discussed previously for use in the immunoincompetency, use of a transparent dressing and
hemodialysis unit. the conditions of catheter placement.
Advantages of these urokinase infusion techniques are
Prevention of infectionthat they appear safe, preserve the catheter and are less
expensive than either fibrin sheath stripping or catheter Prevention of catheter associated infection involves
exchange. The primary disadvantage lies in the fact that three areas: technique of catheter placement, daily cathe-
it requires four to six hours of hospital observation to ter exit site care and catheter management in the hemo-
facilitate payment for the urokinase. In countries or areas dialysis facility. It is critically important that maximal
where time of observation in the hemodialysis unit or barrier precautions be used when a catheter is placed. If
urokinase reimbursement are not barriers these proto- not done in an operating room, the environment should
cols can be adapted to the hemodialysis unit. stimulate an operating room.
Care given to the catheter after placement is of equal
importance. The use of either mupirocin or providone-CATHETER RELATED INFECTION
iodine or other antibiotic ointment at the exit site until
Infection associated with hemodialysis catheters has it is healed has been advocated [55]. The use of a trans-
emerged as the most prominent and most serious compli- parent dressing occlusive dressing has been indicated
cation that is encountered. Tunneled cuffed catheters as a risk factor for CRB [52], since its promotes skin
have a much lower bacteremia rate than that of tempo- colonization. Nevertheless, the question as to whether
rary catheters [2, 3, 45, 46]. The incidence of tunneled
it is best to use gauze or a plastic dressing remains unre-
catheter related bacteremia was recently described by
solved and controversial [54–56]. We adopted the ap-
Marr et al in a large prospective trial as being one episode
proach of keeping of catheter exit site covered with sterileper 252 catheter days [47]. Kovalik and associates dem-
gauze at all times and using providone-iodine ointmentonstrated a significant increase in metastatic infection in
or other antibiotic ointment, in keeping with the DOQIpatients with dialysis catheters versus AV grafts [48].
recommendations. Some polyurethane catheters have de-Robinson and coauthors demonstrated that endocarditis
veloped mechanical breakdown after prolonged exposureoccurred at a much higher rate in patients with catheters
to antibiotic ointments (BARD Inc., Salt Lake City, Utah,as opposed to patients with AV access [49]. Marr and
USA). In these catheters the manufacturer’s recommen-colleagues noted four episodes of endocarditis in patients
dation should be followed.with cuffed tunneled catheters followed for 16,000 cathe-
Most cases of catheter associated infection occur at ater days [47].
point in time distant from the time of insertion. ThisSecondary complications of hemodialysis catheter re-
suggests that factors related to pathogenesis are mostlated bacteremia (CRB) and sepsis such as septic arthri-
likely to be located within the hemodialysis facility, andtis, endocarditis, and epidural abscess have dire conse-
it appears that bacterial colonization plays an importantquences and can result in death [15, 37–49]. Kovalik and
role. Colonization of the patient’s nares, the patient’s skinassociates [48] and Marr and colleagues [47] showed that
and the catheter hub have been examined. Zimakoff etStaphylococcus aureus was much more likely to adhere
al found that catheter-related staphylococdal infection oc-to valve and bone than other organisms. Careful evalua-
curred most often in patients who had nasal colonization,tion for possible metastatic infection is needed when this
and in more than half of the cases it was with the sameorganism is identified.
strain [56]. Nasal carriage can be eliminated [57] but itThe most commonly reported isolate in cases of CRB
is not permanent, and continuous treatment is necessary.has been Staphylococcus aureus [15, 47–50]. In a series
The strategy applied in the hemodialysis facility shouldof 123 cases of CRB, it was observed that 104 cases
be to minimize the effects of bacterial colonization by(84.5%) had Gram positive cocci, 41 (33.3%) had a Gram
minimizing the chances of exposure to these sources ofnegative organism, and 2 (1.6%) had an acid-fast organ-
potential contamination. Analysis of our cases of CRBism [51]. Thirty-seven percent of the cases were second-
revealed that 2/3 of them had no associated exit site orary to Staphylococcus aureus. Multiple organisms were
tunnel infection [50]. This and the fact that the infectionsisolated in 17% of the cases.
were delayed more than two months on average from
Risk factors the time of placement caused us to conclude that contam-
ination of the catheter hub or lumen at the time of manip-In addition to the foreign body effect of the tunneled
cuffed catheter (TCC), there are a number of factors ulation in the dialysis unit was a major risk factor.
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Treatment of infection data. The prolonged empiric use of vancomycin should
be avoided because of the risk of inducing vancomycinInfection associated with a dialysis catheter has the
resistant enterococcus. Initial therapy with vancomycinpotential for being a very serious problem. There are
and an amino glycoside antibiotic until culture resultstwo issues that must be addressed: the infection and what
are available is prudent. Rapid conversion to appropriateto do about the catheter. Conservatively the catheter
antibiotics based on culture sensitivities is needed notshould be removed and should not be replaced until the
only to prevent emergence of resistant organisms, butinfection is clear. Unfortunately, continuing demand for
also to avoid ototoxicity. Antibiotic therapy should bedialysis may preclude the total abandonment of vascular
continued for a minimum of three weeks [47–59]. Bloodaccess. What to do with the catheter as an alternative
cultures should be repeated a week following therapy toto permanent removal must be addressed. The answer
assure that the infection has been eradicated. Routineto this question will depend upon the type of catheter,
evaluation for valvular vegetations by echocardiographythe character of the infection and the patient’s continuing
should be considered. Fowler et al have suggested thatdialysis requirements. Catheter related infection can be
transesophageal echocardiography is essential to estab-classified into three categories; exit site infection, tunnel
lish the diagnosis of endocarditis and should be consid-infection (only with tunnelled catheters), and catheter
ered part of the early evaluation of any patient withrelated bacteremia (CRB). The therapeutic approach to
bacteremia due to Staphylococcus aureus [59]. Appro-each of these is somewhat different.
priate management of the catheter must also be ad-Exit site infection. This is defined as infection localized
dressed. There are several choices: leave the catheter in,to the catheter exit site (external to the anchoring cuff
change the catheter over a guidewire, change the cathe-in cuffed catheters), and is characterized by localized
ter over a guidewire with a new tunnel and exit site, orredness, crusting, and exudate. If the patient has systemic
remove the catheter and delay replacement until thesymptoms and a positive blood culture, the case should
infection has been treated. There are several issues thatbe managed as a CRB below. An exit site infection is a
affect this choice.
local infection. With a temporary catheter, removal of
The presence of a biofilm on the inner or outer surface
the catheter is warranted with replacement at an alter- of the catheter may play an important role in catheter
nate site. Exit site infections associated with a tunneled related bacteremia [60, 61]. Bacteria adhere and become
catheter should be treated with local measures (cleaning embedded in the glycocalyx of the biofilm making them
with a topical disinfectant and use of a topical antibiotic) more resistant to antibiotics than those floating in the
in a salvage attempt if there is continued need for its circulation [60, 62]. Passerini et al demonstrated the pres-
use [58]. Systemic antibiotics are necessary in more se- ence of a biofilm on the surface of 100% of the central
vere cases or in cases that fail to respond to topical venous catheters removed from 26 ICU patients [63].
therapy. Antibiotics with anti-staphyloccal properties Some of these catheters had been in place for only one
are preferred. Cases that fail to respond quickly to local day. Bacteria were demonstrated within 88% of these
measures and antibiotics necessitate catheter removal to biofilms.
prevent bacteremia. From a purely infectious disease viewpoint, removal of
Tunnel infection. By definition, tunnel infections oc- the catheter appears to be important [63–69] and where
cur only with tunneled catheters. This category of infec- possible, this course of action should be followed. How-
tion is defined as involvement within the catheter tunnel ever, in the dialysis patient the issue is complicated by
internal to the anchoring cuff. Involvement of the tunnel the fact that the patient must continue to receive dialysis
external to the cuff is commonly seen as part of the exit treatments. Removal of a tunneled catheter creates a
site infection. When the tunnel is infected internal to the requirement for the use of temporary catheters and the
cuff, it is a serious problem because the catheter moves risk of their associated complications. It mandates multi-
back and forth within this portion of the tunnel and there ple procedures, a period of hospitalization and increased
is often direct communication with the blood stream. costs. Additionally, removal of the catheter may be asso-
When it appears that the patient has a tunnel infection, ciated with a loss of the central venous entry site because
the blood cultures are often found to be positive, thus, of stenosis or thrombosis. Unnecessary loss of a central
it is actually a tunnel mediated CRB. Appropriate treat- venous site should be avoided if salvage of the site does
ment consists of parenteral antibiotics according to cul- not jeopardize the patient’s health.
ture results and catheter removal. The catheter should Saltissi and Macfarlane suggested treating the patient
not be replaced at this site. with the catheter in place [64]. However, in an attempt
Catheter related bacteremia. When a catheter patient to do this, Marr et al observed a failure rate of 68%
presents with a positive blood culture, immediate and even with prolonged antimicrobial therapy [47]. This
prolonged antibiotic treatment is essential. The antibi- study indicates that this approach should not be consid-
ered as a therapeutic option.otic used must be based upon culture and sensitivity
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Fig. 10. Management of catheter related bac-
teremia (flow diagram).
Shaffer, however, demonstrated encouraging results in exchange. They reported a success rate of 82%. In a
series of 49 patients with minimal symptoms and no exita small series of patients treated with guidewire catheter
exchange, new tunnel creation and antibiotic therapy for site infection, an 87% cure rate for CRB was obtained
utilizing catheter exchange over a guidewire 24 to 48 hourscatheter related bacteremia in cuffed tunneled catheters
[45]. Robinson et al reported a series of 23 hemodialysis after initiation of empiric antibiotics followed by three
weeks of continued specific antibiotic treatment [50].tunneled catheter patients with CRB who were treated
with catheter exchange over a guidewire combined with These studies confirm that catheter exchange over a guide-
wire combined with three weeks of specific antibioticthree weeks of antibiotic therapy [70]. These were pa-
tients with no evidence of tunnel infection who had de- therapy is a viable treatment option for a subset of pa-
tients with CRB. Failure to respond rapidly to antibioticfervesced within 48 hours of beginning empiric antibiotic
therapy. They defined technique failure as a repeat infec- therapy or an inflamed tunnel track require immediate
catheter removal combined with antibiotic therapy [71].tion with any organism within 90 days of the catheter
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In patients who have exit site or tunnel infections, the SUMMARY
catheter must be removed and a new tunnel and exit Our ability to care for the dialysis-dependent patient
site must be created when it is replaced. To do otherwise with chronic renal failure has been considerable en-
exposes the patient to unacceptable risks. In one report, hanced by the development and availability of catheters,
a series of 37 cases of CRB in tunneled catheter patients both temporary and chronic. There is no question that
the development of these devices has been a tremendouswith severe symptoms of septicemia were treated by
asset to the nephrologist. However, it is equally obviousremoving the catheter, starting antibiotics and replacing
that their use carries a price measured in patient morbid-the catheter at a new site as soon as the patients had
ity and physician frustration. They truly represent a dou-become afebrile [50]. Specific antibiotic therapy was con-
ble-edged sword. It is important that we develop a cathe-tinued for a total duration of three weeks. A cure rate
ter usage strategy based upon an understanding of theof 87% was obtained in these patients. Thus, replacing
complications that can occur with the use of these de-the catheter at a new site 24 to 48 hours after the patient
vices, and the appropriate preventive and therapeutichas become afebrile is successful in the vast majority of
measures necessary to address these complications. It is
patients. Removal of the catheter during an episode of
also important that we come to grips with the fact that a
infection is always the correct option if there is any doubt catheter is inferior to and not a substitute for a peripheral
about the status of the patient or the catheter tunnel access, not for an AV bridge graft and certainly not for
track. It is practice at our institution to require that the an arteriovenous fistula. Early elective placement of an
patient be afebrile and blood cultures be negative during AV fistula is the best way to avoid the complications of
antibiotic therapy prior to catheter replacement. These hemodialysis catheters.
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